LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

AZN

185.31

+0.58%↑

LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

AZN

185.31

+0.58%↑

LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

AZN

185.31

+0.58%↑

LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

AZN

185.31

+0.58%↑

LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

AZN

185.31

+0.58%↑

Search

Guardant Health Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

83.3 -1.77

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

82.29

Max

85

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-36M

-128M

Pardavimai

16M

281M

Pelnas, tenkantis vienai akcijai

-0.5

Pelno marža

-45.684

Darbuotojai

2,490

EBITDA

-37M

-119M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+56.21% upside

Dividendai

By Dow Jones

Kitas uždarbis

2026-04-29

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-2.2B

11B

Ankstesnė atidarymo kaina

85.07

Ankstesnė uždarymo kaina

83.3

Naujienos nuotaikos

By Acuity

50%

50%

171 / 350 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

Guardant Health Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-24 18:58; UTC

Pagrindinės rinkos jėgos

MDA Space Shares Drop After NASA Shifts Focus to Moon's Surface and Away From Space Station

2026-03-24 23:48; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-03-24 23:48; UTC

Rinkos pokalbiai

Nikkei May Rise on Hopes for U.S.-Iran Talks -- Market Talk

2026-03-24 23:33; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Gold Rises, Boosted by Dollar Weakness -- Market Talk

2026-03-24 23:16; UTC

Rinkos pokalbiai

Venezuelan Opposition Leader Says Oil Output Could Reach 5 Million B/D -- Market Talk

2026-03-24 22:40; UTC

Uždarbis

Shanghai Fosun Pharmaceutical: Results Supported by Higher Rev From Innovative Drugs, Overseas Business >2196.HK

2026-03-24 22:40; UTC

Uždarbis

Shanghai Fosun Pharmaceutical 2025 Net CNY3.37B Vs. Net CNY2.77B >2196.HK

2026-03-24 22:40; UTC

Uždarbis

Shanghai Fosun Pharmaceutical 2025 Rev CNY41.50B Vs. CNY40.91B >2196.HK

2026-03-24 21:44; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-03-24 21:44; UTC

Rinkos pokalbiai

Sandfire's New Bull Excited by Kalkaroo Copper Deposit -- Market Talk

2026-03-24 20:59; UTC

Uždarbis

Medtronic PLC Cuts FY26 View To Adj EPS $5.50-Adj EPS $5.54 >MDT

2026-03-24 20:58; UTC

Svarbiausios naujienos

Israel Hits Russian-Iranian Weapons Smuggling Route in the Caspian Sea -- WSJ

2026-03-24 20:50; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Energy & Utilities Roundup: Market Talk

2026-03-24 20:50; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Basic Materials Roundup: Market Talk

2026-03-24 20:50; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2026-03-24 20:25; UTC

Uždarbis

This Palantir-Linked Drone Stock Was Flying Under the Radar -- Until Now -- Barrons.com

2026-03-24 20:15; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Global Commodities Roundup: Market Talk

2026-03-24 20:10; UTC

Rinkos pokalbiai

Canada Mortgage Arrears Linked to Labor Market Performance -- Market Talk

2026-03-24 20:10; UTC

Uždarbis

Worthington Enterprises 3Q Sales $378.7M >WOR

2026-03-24 20:10; UTC

Uždarbis

Worthington Enterprises 3Q Adj EPS 98c >WOR

2026-03-24 20:10; UTC

Uždarbis

Worthington Enterprises 3Q EPS 92c >WOR

2026-03-24 19:25; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Canada Needs Roughly 100 Days to Meet IEA's Oil-Stock Release -- Market Talk

2026-03-24 19:06; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Oil Futures Regain Ground As Strikes Continue in Middle East -- Market Talk

2026-03-24 18:51; UTC

Rinkos pokalbiai
Svarbiausios naujienos

U.S. Natural Gas Settles Higher As Oil Futures Gain -- Market Talk

2026-03-24 18:40; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Global Forex and Fixed Income Roundup: Market Talk

2026-03-24 18:40; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Mideast Conflict to Hobble But Not Derail Canadian Economy -- Market Talk

2026-03-24 18:34; UTC

Svarbiausios naujienos

Oil Production in the Middle East Will Take Months to Come Back, CEO says. Why $100 Oil Could Be Here to Stay. -- Barrons.com

2026-03-24 18:27; UTC

Rinkos pokalbiai

Inflation Pickup Could Keep Bank of Mexico on Hold -- Market Talk

2026-03-24 18:21; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Silver Snaps 9-Session Losing Streak -- Market Talk

2026-03-24 18:00; UTC

Įsigijimai, susijungimai, perėmimai

Gilead to Buy Ouro Medicines for $2.2 Billion. Why the Deal Is Key to Future Stock Gains. -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Guardant Health Inc Prognozė

Kainos tikslas

By TipRanks

56.21% į viršų

12 mėnesių prognozė

Vidutinis 132.72 USD  56.21%

Aukščiausias 175 USD

Žemiausias 110 USD

Remiantis 20 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Guardant Health Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

20 ratings

19

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

38.86 / 47.41Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bearish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Bullish Evidence

Rinkos nuotaikos

By Acuity

171 / 350 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Vidutinis

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Guardant Health Inc

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research; and with ConcertAI to form first data-as-a-service that integrates clinical and tumor profiling data to accelerate cancer therapy research and development. The company was incorporated in 2011 and is headquartered in Palo Alto, California.
help-icon Live chat